Scope Fluidics S.A.

SCP

PLSCPFL00018

Biotechnology & Medical Research

Delayed Warsaw S.E. 11:41:18 08/10/26 pm AEDT			5-day change	1st Jan Change
127.60 ^PLN	-1.24%		+4.59%	-6.31%

30/09	Scope Fluidics S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/05	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE

Scope Fluidics starts ABB process

Published on 10/27/2025 at 06:06 pm AEDT

Reuters

This article is reserved for our members.

Continue with Google Continue with Apple Continue with LinkedIn

or by email

Continue with an email.

Latest news about Scope Fluidics S.A.

30/09	Scope Fluidics S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/05	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
15/05	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE
15/05	Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
22/04	Scope Fluidics unit Bacteromic starts collaboration with US research center for FDA registration trials	RE
25/03	Scope Fluidics FY net loss at 46.4 million zlotys	RE
25/03	Scope Fluidics S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
10/03	Scope Fluidics updates objectives for Bacteromic project for 2026-2027	RE
20/02	Scope Fluidics obtains CE-IVDR certification for Bacteromic System	RE
12/02	Scope Fluidics unit adopts plan for production readiness for Bacteromic system panels	RE
21/01	Scope Fluidics unit signs framework distribution deal with SC Elta 90 Medical Research	RE
09/01	Scope Fluidics signs distribution deal for Bacteromic system in Turkey	RE
24/12	Scope Fluidics says unit Bacteromic ends cooperation with MicroLiquid	RE
13/12	Scope Fluidics says unit receives conditional grant approval for Hybolic project	RE
02/12	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

Employees

Sector

Biotechnology & Medical Research

Calendar

30/11 Earnings release - Q3 2026

More about the company